CoverageForm 410-K10-Q8-K13D13G13F

Henderson Jane

CIK 0001422304
Chief Financial OfficerDirector

Filings

30

Latest May 4, 2026

Issuers covered

5

Showing

30 of 30

Page 1

Track record

23 of 26 open-market trades scored (88% price coverage) - 3 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

HorizonTradesWin rateAvgMedianBestWorst
30 days2339%-5.2%-9.0%+20.6%-21.6%
90 days1631%-8.7%-11.3%+12.8%-27.3%
180 days520%-10.7%-16.8%+29.9%-34.4%
365 days1100%+23.6%+23.6%+23.6%+23.6%

Issuers

Companies where Henderson Jane has filed

TickerIssuerFilingsLast filed
APGEApogee Therapeutics, Inc.15May 4, 2026
AKROAkero Therapeutics, Inc.7Dec 9, 2025
ISEEIveric Bio, Inc.4Jul 13, 2023
CRGXCargo Therapeutics, Inc.3Aug 19, 2025
IVVDInvivyd, Inc.1Feb 1, 2022

All filings

30 Form 4 / 4-A filings, newest first

Sign in to download
Filed Top transactionSharesPriceValue